NEKTAR THERAPEUTICS Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nektar Therapeutics quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Nektar Therapeutics Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$52.4M, a 2.43% decline year-over-year.
  • Nektar Therapeutics Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$177M, a 42.3% increase year-over-year.
  • Nektar Therapeutics annual Net Income (Loss) Attributable to Parent for 2023 was -$276M, a 25% increase from 2022.
  • Nektar Therapeutics annual Net Income (Loss) Attributable to Parent for 2022 was -$368M, a 29.7% increase from 2021.
  • Nektar Therapeutics annual Net Income (Loss) Attributable to Parent for 2021 was -$524M, a 17.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$276M +$92.1M +25% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$368M +$156M +29.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$524M -$79.4M -17.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 -$444M -$3.77M -0.86% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$441M -$1.12B -165% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $681M +$778M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$96.7M +$56.8M +37% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 -$154M -$72.3M -89.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$81.2M -$27.3M -50.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$53.9M +$108M +66.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$162M +$9.84M +5.73% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
2012 -$172M -$37.9M -28.3% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
2011 -$134M -$96M -253% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-27
2010 -$37.9M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.